PharmaNet Technology introduces Initiator, PKS
The platforms will provide improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. PharmaNet, with the
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Accovion provides study planning and management, clinical monitoring, pharmacovigilance including post-marketing safety, data management, biostatistics, statistical programming, medical writing and electronic publishing. Accovion chief operating officer Ivana Waller